Pangaea Global AIDS Foundation was founded in 2001 by the San Francisco AIDS Foundation in response to the global imperative to expand access to HIV/AIDS care and treatment in developing countries. Based in San Francisco, California, Pangaea established a core team with depth in clinical HIV/AIDS, health care provider training, policy development, national level HIV/AIDS strategic planning and implementation, monitoring and evaluation, and program and fiscal management.
Pangaea’s early work focused on broadening access to HIV antiretroviral therapy with projects in Rwanda, South Africa and Uganda. Working with various national and international partners, Pangaea helped develop early HIV/AIDS treatment sites in resource constrained settings and assisted national health ministries in the development of country-wide AIDS treatment plans.
While continuing work in Africa, Pangaea broadened its efforts to include the planning and implementation of large scale treatment access projects in Asia and Eastern Europe, with special emphasis on HIV epidemics fueled by injection drug use. Pangaea also assisted partners in the private sector to maximize HIV prevention and treatment efforts, including the creation of a model clinic and training center funded by Pfizer Inc at Makerere University in Kampala, Uganda and the planning and implementation of a worldwide employee HIV/AIDS training and treatment program for Chevron.